Infection Control Plus helps its clients to improve patient safety and prevent infection. Our clients work in clinical and commercial settings around the world.
Infection Control Plus specialises in analysis of research, public policy and clinical trends. We use that analysis and our deep connection to the global infection control community to develop high quality, customized and practical solutions for our customers. Our fees are competitive and reflect current market norms.
What our clients are saying…
“Our business is about helping people and healthcare systems fight the challenge of bacterial biofilms in an effective way and without the insight and knowledge of Dr Cathryn Murphy, we wouldn’t be as effective as what we are. It is an absolute pleasure working with her and Infection Control Plus.”
“Infection Control Plus is essential to Ansell Cares continuing education for the safety of healthcare workers”.
“The insights provided by Infection Control Plus are invaluable to the way we look at our markets, both locally and globally. Their depth of knowledge and experience is unrivalled by any others we have dealt with in this space”.
“Infection Control Plus provides infection control related services across several clinical areas including hand hygiene, operating rooms, reprocessing and vascular access. I have always found Cathryn Murphy to be current, focused and innovative in meeting the clinical and educational needs of our customers in various regions of the world.”
“Infection Control Plus brings an unparalleled level of knowledge, capacity for collaboration & professionalism to any Infection Control and Prevention endeavor; they are a joy to work with”.
“Johnson & Johnson Medical has enjoyed a long and productive relationship with Infection Control Plus, since 2004. Both Cath Murphy and Sue Resnik bring not only exceptional expertise in the Infection Prevention space, but an innovative and creative approach. Their expertise, insight and approach have strongly contributed to better patient solutions across our portfolio.“